190 related articles for article (PubMed ID: 11798400)
1. Aspirin versus clopidogrel for synthetic graft patency after peripheral arterial bypass grafting.
Duran E; Canbaz S; Ege T; Acipayam M
Platelets; 2001 Dec; 12(8):503-4. PubMed ID: 11798400
[No Abstract] [Full Text] [Related]
2. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
Gao C; Ren C; Li D; Li L
Ann Thorac Surg; 2009 Jul; 88(1):59-62. PubMed ID: 19559191
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
Milani RV
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S7-S11. PubMed ID: 19213064
[TBL] [Abstract][Full Text] [Related]
4. [Myocardial infarct, stroke and vascular events reduced by a third].
Z Kardiol; 1997 Nov; 86(11 Suppl Myokardinf):1-3. PubMed ID: 9437253
[No Abstract] [Full Text] [Related]
5. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation: 1 and 6-month follow-up.
Piamsomboon C; Laothavorn P; Chatlaong B; Saguanwong S; Nasawadi C; Tanprasert P; Leelaprute M; Intayakorn U; Amornsak N
J Med Assoc Thai; 2001 Dec; 84(12):1701-7. PubMed ID: 11999816
[TBL] [Abstract][Full Text] [Related]
6. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.
Belch JJ; Dormandy J; ; Biasi GM; Cairols M; Diehm C; Eikelboom B; Golledge J; Jawien A; Lepäntalo M; Norgren L; Hiatt WR; Becquemin JP; Bergqvist D; Clement D; Baumgartner I; Minar E; Stonebridge P; Vermassen F; Matyas L; Leizorovicz A
J Vasc Surg; 2010 Oct; 52(4):825-33, 833.e1-2. PubMed ID: 20678878
[TBL] [Abstract][Full Text] [Related]
7. Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery.
Ibrahim K; Tjomsland O; Halvorsen D; Wiseth R; Wahba A; Karevold A; Haaverstad R
Heart Surg Forum; 2006; 9(6):E581-856. PubMed ID: 17060036
[TBL] [Abstract][Full Text] [Related]
8. Risk reduction with clopidogrel in the management of peripheral arterial disease.
Nayak KR; Cavendish JJ
Vasc Health Risk Manag; 2007; 3(3):289-97. PubMed ID: 17703636
[TBL] [Abstract][Full Text] [Related]
9. Aspirin and clopidogrel resistance-a myth or reality: an update.
Gupta S; Gupta MM
Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
[No Abstract] [Full Text] [Related]
10. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease.
Addad F; Chakroune T; Asma A; Abderazek F; Zohra D; Ghrissi I; Hassine M; Gamra H; Elalamy I
Thromb Res; 2009 Feb; 123(4):640-3. PubMed ID: 18602138
[No Abstract] [Full Text] [Related]
11. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
[TBL] [Abstract][Full Text] [Related]
12. Invited commentary.
Esposito RA
Ann Thorac Surg; 2009 Jul; 88(1):62-3. PubMed ID: 19559192
[No Abstract] [Full Text] [Related]
13. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
Mani H; Lindhoff-Last E
Pharm Unserer Zeit; 2009; 38(4):342-50. PubMed ID: 19572355
[No Abstract] [Full Text] [Related]
15. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
[No Abstract] [Full Text] [Related]
16. Antiplatelet therapy and patency of saphenous-vein bypass grafts in the legs.
Conte MS; Belkin M; Donaldson MC; Whittemore AD
N Engl J Med; 1998 May; 338(19):1387-8. PubMed ID: 9575054
[No Abstract] [Full Text] [Related]
17. Prevention of venous graft sclerosis with clopidogrel and aspirin combined with a mesh tubing in a dog model of arteriovenous bypass grafting.
Zurbrügg HR; Musci M; Sänger S; Gutersohn A; Mülling C; Wellnhofer E; Schaffner T; Hetzer R
Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):337-41. PubMed ID: 11563893
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the preoperative aspirin and postoperative antiplatelets in coronary artery bypass grafting surgery.
Refiker M
Am Heart J; 2011 May; 161(5):e25; author reply e27. PubMed ID: 21570501
[No Abstract] [Full Text] [Related]
19. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
[No Abstract] [Full Text] [Related]
20. Regarding "results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial".
Conte MS
J Vasc Surg; 2011 May; 53(5):1453-4; author reply 1454. PubMed ID: 21575762
[No Abstract] [Full Text] [Related]
[Next] [New Search]